Fulgent Genetics FLGT 深 沪
交易中 11-06 10:24:45 美东时间
22.50
-0.280
-1.23%
华盛通- 最 高22.8913
- 今 开22.66
- 成交量 1.32万股
- 最 低 22.50
- 昨 收 22.78
- 总市值 6.89亿
- 52周最高 24.64
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 14.57
- 委 比 81.56%
- 总股本 3060.90万
- 历史最高 189.89
- 量 比 0.58
- 振 幅 1.72%
- 历史最低 2.725
- 每 手 1
- 风险率 2.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fulgent Genetics's Earnings Outlook
Fulgent Genetics (NASDAQ:FLGT) is gearing up to announce its quarterly earnings...
21分钟前
A Glimpse of Castle Biosciences's Earnings Potential
Castle Biosciences (NASDAQ:CSTL) will release its quarterly earnings report on ...
11-01 03:03
Fulgent Genetics Reports Phase 2 Cancer Drug Results Ahead Of ESMO 2025 Presentation
Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced preliminary
10-20 18:11
A Preview Of Performant Healthcare's Earnings
Performant Healthcare (NASDAQ:PHLT) is gearing up to announce its quarterly ear...
08-07 03:03
UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30
UBS analyst Lu Li upgrades Fulgent Genetics (NASDAQ:FLGT) from Neutral to Buy and raises the price target from $20 to $30.
08-05 19:19
美股大行评级 | 潜在涨幅123.33%！Maxim Group上调优利系统目标价至9美元，评级升至"买入"
今日重点评级关注：Maxim Group：上调优利系统评级至"买入"，目标价9美元；Canaccord Genuity：维持Enovix"买入"评级，目标价从20美元升至22美元
08-05 08:35
Fulgent Genetics Reports Strong Core Revenue Growth
Fulgent Genetics ( ($FLGT) ) has released its Q2 earnings. Here is a breakdown ...
08-02 12:27
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling around 500 points on F...
08-01 22:44
Fulgent Genetics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance above estimates.
Fulgent Genetics shares are trading higher after the company reported better-th...
08-01 21:03
Fulgent Genetics Raises FY2025 Adj EPS Guidance from $(0.65) to $(0.35) vs $(0.55) Est; Raises FY2025 Sales Guidance from $310.000M to $320.000M vs $310.682M Est
Fulgent Genetics (NASDAQ:FLGT) raises FY2025 Adj EPS guidance from $(0.65) to $(0.35) vs $(0.55) analyst estimate. Raises FY2025 sales outlook from $310.000 million to $320.000 million vs $310.682 million estimate.
08-01 19:04
